View Author
fdg-pet esophageal cancer tumor cancer esophageal patient model outcome result pet /ct length imaging resectable regression resectability netherland histological type signi tomography study table center 0.001 lymph nodes preoperative positron emission tomography signi ficantly procedure \0.001 method surgery treatment value metastase regression approach tumor length university disease eus-fna characteristic lymph emission positron groningen histological ficant department likelihood ratio center groningen likelihood unresectable ct results fdg-pet results ratio neoadjuvant 0.14 workup amsterdam approach 0.53 order neoadjuvant chemoradiation scenario 2.91 fi ne-needle aspiration odds model irresectable esophageal tumors 0.92 assessment test results strategy van westreenen hl tumor invasion signi ficant relation fi rst regression analyses ficantly sequence lymph node metastases true-negative test outcomes
1 Most Recent Publications
|
Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
(Article)
Schreurs, L.M.A. Janssens, A.C.J.W. Plukker, J.T. Groen, H.J.M. Fockens, P. Dullemen, H.M. van Berge Henegouwen, M.I. van Sloof, G.W. Pruim, J. Lanschot, J.J.B. van Steyerberg, E.W. |
2011-05-06
|